|
1
|
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
|
N Engl J Med
|
2006
|
18.25
|
|
2
|
Universal definition of myocardial infarction.
|
Circulation
|
2007
|
11.69
|
|
3
|
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
|
N Engl J Med
|
2006
|
11.66
|
|
4
|
Third universal definition of myocardial infarction.
|
J Am Coll Cardiol
|
2012
|
8.59
|
|
5
|
Third universal definition of myocardial infarction.
|
Circulation
|
2012
|
8.47
|
|
6
|
Third universal definition of myocardial infarction.
|
Eur Heart J
|
2012
|
7.98
|
|
7
|
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.
|
Lancet
|
2009
|
6.82
|
|
8
|
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.
|
Eur Heart J
|
2007
|
6.51
|
|
9
|
Circulating microRNAs in patients with coronary artery disease.
|
Circ Res
|
2010
|
6.28
|
|
10
|
Prehospital ticagrelor in ST-segment elevation myocardial infarction.
|
N Engl J Med
|
2014
|
5.25
|
|
11
|
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.
|
Lancet
|
2010
|
4.72
|
|
12
|
Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.
|
Eur Heart J
|
2006
|
4.69
|
|
13
|
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
|
Circulation
|
2003
|
4.36
|
|
14
|
Effect of platelet inhibition with cangrelor during PCI on ischemic events.
|
N Engl J Med
|
2013
|
4.16
|
|
15
|
Soluble CD40 ligand in acute coronary syndromes.
|
N Engl J Med
|
2003
|
4.06
|
|
16
|
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
|
Circulation
|
2002
|
3.48
|
|
17
|
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
|
Eur Heart J
|
2002
|
3.36
|
|
18
|
Bivalirudin started during emergency transport for primary PCI.
|
N Engl J Med
|
2013
|
2.80
|
|
19
|
Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque.
|
Circulation
|
2008
|
2.62
|
|
20
|
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
|
J Am Coll Cardiol
|
2007
|
2.56
|
|
21
|
Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study.
|
J Am Coll Cardiol
|
2008
|
2.31
|
|
22
|
Mechanisms of stress (Takotsubo) cardiomyopathy.
|
Nat Rev Cardiol
|
2010
|
2.13
|
|
23
|
Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
|
J Am Coll Cardiol
|
2005
|
2.07
|
|
24
|
Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction.
|
Circ Heart Fail
|
2009
|
2.01
|
|
25
|
Bone marrow-derived cells contribute to infarct remodelling.
|
Cardiovasc Res
|
2006
|
2.00
|
|
26
|
Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy.
|
Eur Heart J
|
2009
|
1.90
|
|
27
|
Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards?
|
J Am Coll Cardiol
|
2003
|
1.88
|
|
28
|
A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts.
|
J Am Coll Cardiol
|
2003
|
1.85
|
|
29
|
Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery.
|
Eur Heart J
|
2007
|
1.81
|
|
30
|
Abnormalities in intracellular Ca2+ regulation contribute to the pathomechanism of Tako-Tsubo cardiomyopathy.
|
Eur Heart J
|
2009
|
1.78
|
|
31
|
Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes.
|
Circulation
|
2003
|
1.67
|
|
32
|
The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II).
|
Eur Heart J
|
2007
|
1.60
|
|
33
|
Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation.
|
Europace
|
2010
|
1.59
|
|
34
|
Activated cell survival cascade protects cardiomyocytes from cell death in Tako-Tsubo cardiomyopathy.
|
Eur J Heart Fail
|
2009
|
1.57
|
|
35
|
Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher Registry.
|
Circulation
|
2009
|
1.54
|
|
36
|
Cardiac troponin elevations in patients without acute coronary syndrome.
|
Circulation
|
2002
|
1.53
|
|
37
|
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease.
|
Eur Heart J
|
2009
|
1.49
|
|
38
|
Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery.
|
Eur Heart J
|
2012
|
1.48
|
|
39
|
Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
|
JACC Cardiovasc Imaging
|
2010
|
1.47
|
|
40
|
The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials.
|
J Am Coll Cardiol
|
2012
|
1.46
|
|
41
|
Predictors and outcome of grade 3 ischemia in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
|
J Electrocardiol
|
2011
|
1.45
|
|
42
|
Prognostic value of the modified American College of Cardiology/American Heart Association lesion morphology classification for clinical outcome after sirolimus-eluting stent placement (results of the prospective multicenter German Cypher Registry).
|
Am J Cardiol
|
2007
|
1.44
|
|
43
|
Which standard biomarkers are useful for the evaluation of myocardial injury after pulmonary vein isolation with cryoballoon?
|
Kardiol Pol
|
2011
|
1.41
|
|
44
|
Elevated serum levels of neuropeptide Y in stress cardiomyopathy.
|
Int J Cardiol
|
2010
|
1.41
|
|
45
|
Prognostic value of placental growth factor in patients with acute chest pain.
|
JAMA
|
2004
|
1.40
|
|
46
|
Major determinants of myocardial injury after pulmonary vein isolation with radiofrequency ablation.
|
Kardiol Pol
|
2012
|
1.39
|
|
47
|
Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
|
Eur Heart J
|
2010
|
1.36
|
|
48
|
N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
|
Circulation
|
2004
|
1.27
|
|
49
|
Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.
|
J Am Coll Cardiol
|
2006
|
1.15
|
|
50
|
Prospective randomized comparison of durability of bidirectional conduction block in the cavotricuspid isthmus in patients after ablation of common atrial flutter using cryothermy and radiofrequency energy: the CRYOTIP study.
|
Heart Rhythm
|
2009
|
1.14
|
|
51
|
Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.
|
Circulation
|
2003
|
1.12
|
|
52
|
Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry).
|
Am J Cardiol
|
2005
|
1.11
|
|
53
|
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.
|
Int J Cardiol
|
2013
|
1.11
|
|
54
|
Pulmonary vein diameter reduction after radiofrequency catheter ablation for paroxysmal atrial fibrillation evaluated by contrast-enhanced three-dimensional magnetic resonance imaging.
|
Circulation
|
2003
|
1.11
|
|
55
|
TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY).
|
EuroIntervention
|
2014
|
1.10
|
|
56
|
Outcomes of atrial fibrillation ablation in patients with metabolic syndrome.
|
J Am Coll Cardiol
|
2013
|
1.06
|
|
57
|
N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
|
J Am Coll Cardiol
|
2008
|
1.05
|
|
58
|
Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial.
|
Eur J Heart Fail
|
2009
|
1.05
|
|
59
|
Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial.
|
Am Heart J
|
2012
|
1.05
|
|
60
|
Relationship between palpography and virtual histology in patients with acute coronary syndromes.
|
JACC Cardiovasc Imaging
|
2012
|
1.04
|
|
61
|
Acute coronary syndrome: the risk of being female.
|
Circulation
|
2004
|
1.02
|
|
62
|
[Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
|
Herz
|
2004
|
1.01
|
|
63
|
How to manage patients with need for antiplatelet therapy in the setting of (un-)planned surgery.
|
Clin Res Cardiol
|
2008
|
0.99
|
|
64
|
MEDAFI-Trial (Micro-embolization during ablation of atrial fibrillation): comparison of pulmonary vein isolation using cryoballoon technique vs. radiofrequency energy.
|
Europace
|
2010
|
0.98
|
|
65
|
Cryoballoon ablation of paroxysmal atrial fibrillation: 5-year outcome after single procedure and predictors of success.
|
Europace
|
2013
|
0.98
|
|
66
|
Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis.
|
Int J Cardiovasc Imaging
|
2011
|
0.97
|
|
67
|
Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST).
|
Circulation
|
2002
|
0.97
|
|
68
|
[Percutaneous coronary interventions (PCI)].
|
Clin Res Cardiol
|
2008
|
0.96
|
|
69
|
Detection of relevant coronary artery disease using dual-source computed tomography in a high probability patient series: comparison with invasive angiography.
|
Circ J
|
2008
|
0.96
|
|
70
|
Use of automatic exposure control in multislice computed tomography of the coronaries: comparison of 16-slice and 64-slice scanner data with conventional coronary angiography.
|
Heart
|
2007
|
0.95
|
|
71
|
Temporary third-degree atrioventricular block in a case of apical ballooning syndrome.
|
Int J Cardiol
|
2006
|
0.95
|
|
72
|
Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina.
|
Int J Cardiol
|
2010
|
0.95
|
|
73
|
[ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)].
|
G Ital Cardiol (Rome)
|
2012
|
0.95
|
|
74
|
Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): an international randomized open-label ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myocardial infarction transferred for primary percutaneous coronary intervention.
|
Am Heart J
|
2013
|
0.95
|
|
75
|
Release pattern of cardiac biomarkers in left ventricular apical ballooning.
|
Int J Cardiol
|
2007
|
0.94
|
|
76
|
Expression profiling of cardiac genes in Tako-Tsubo cardiomyopathy: insight into a new cardiac entity.
|
J Mol Cell Cardiol
|
2007
|
0.93
|
|
77
|
Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation.
|
Basic Res Cardiol
|
2012
|
0.92
|
|
78
|
Venn diagrams in cardiovascular disease: the Heart Team concept.
|
Eur Heart J
|
2013
|
0.91
|
|
79
|
Molecular basis of disturbed extracellular matrix homeostasis in stress cardiomyopathy.
|
Int J Cardiol
|
2013
|
0.91
|
|
80
|
13-year follow-up of the German angioplasty bypass surgery investigation.
|
Eur Heart J
|
2005
|
0.90
|
|
81
|
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
|
J Thromb Thrombolysis
|
2012
|
0.90
|
|
82
|
Invasive optimization of cardiac resynchronization therapy: role of sequential biventricular and left ventricular pacing.
|
Pacing Clin Electrophysiol
|
2005
|
0.90
|
|
83
|
NT-ProBNP predicts rhythm stability after cardioversion of lone atrial fibrillation.
|
Circ J
|
2008
|
0.90
|
|
84
|
Pulmonary vein stenting for the treatment of acquired severe pulmonary vein stenosis after pulmonary vein isolation: clinical implications after long-term follow-up of 4 years.
|
J Cardiovasc Electrophysiol
|
2009
|
0.89
|
|
85
|
Ischemia triggers BNP expression in the human myocardium independent from mechanical stress.
|
Int J Cardiol
|
2009
|
0.89
|
|
86
|
Repeated catheter ablation of atrial fibrillation: how to predict outcome?
|
Circ J
|
2013
|
0.88
|
|
87
|
Delayed contrast-enhanced magnetic resonance imaging for the detection of autoimmune myocarditis and long-term follow-up.
|
J Cardiovasc Magn Reson
|
2005
|
0.88
|
|
88
|
Preprocedural coronary CT angiography significantly improves success rates of PCI for chronic total occlusion.
|
Int J Cardiovasc Imaging
|
2013
|
0.88
|
|
89
|
Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry.
|
Int J Cardiol
|
2011
|
0.87
|
|
90
|
A novel mutation in the cardiac ryanodine receptor gene (RyR2) in a patient with an unequivocal LQTS.
|
Int J Cardiol
|
2010
|
0.87
|
|
91
|
One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial).
|
EuroIntervention
|
2005
|
0.87
|
|
92
|
Diagnostic accuracy of computed tomography angiography for the detection of coronary artery disease in patients referred for transcatheter aortic valve implantation.
|
Clin Res Cardiol
|
2015
|
0.87
|
|
93
|
How to revascularize patients with diabetes mellitus: bypass or stents and drugs?
|
Clin Res Cardiol
|
2006
|
0.87
|
|
94
|
The study of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): design and rationale.
|
Am Heart J
|
2012
|
0.86
|
|
95
|
Quality-of-life in patients with paroxysmal atrial fibrillation after catheter ablation: results of long-term follow-up.
|
Pacing Clin Electrophysiol
|
2003
|
0.86
|
|
96
|
Image quality on dual-source computed-tomographic coronary angiography.
|
Eur Radiol
|
2008
|
0.86
|
|
97
|
Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-1β synthesis.
|
Eur Heart J
|
2011
|
0.86
|
|
98
|
Release kinetics of circulating cardiac myosin binding protein-C following cardiac injury.
|
Am J Physiol Heart Circ Physiol
|
2013
|
0.86
|
|
99
|
Maladaptive hypertrophy after acute myocardial infarction positive effect of bone marrow-derived stem cell therapy on regional remodeling measured by cardiac MRI.
|
Clin Res Cardiol
|
2011
|
0.86
|
|
100
|
Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial.
|
Arch Cardiovasc Dis
|
2009
|
0.85
|
|
101
|
Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
|
Eur Heart J
|
2009
|
0.85
|
|
102
|
Percutaneous pulmonary vein stenting for the treatment of severe stenosis after pulmonary vein isolation.
|
J Cardiovasc Electrophysiol
|
2005
|
0.85
|
|
103
|
Acute and long-term results of PVI at antrum using a novel high-density mapping catheter without help of 3D electro-anatomic mapping in patients with paroxysmal and chronic atrial fibrillation.
|
J Interv Card Electrophysiol
|
2010
|
0.85
|
|
104
|
Impact of impaired renal function and metabolic syndrome on the recurrence of atrial fibrillation after catheter ablation: a long term follow-up.
|
Pacing Clin Electrophysiol
|
2012
|
0.84
|
|
105
|
Value of gadolinium-enhanced magnetic resonance imaging in patients with Tako-Tsubo-like left ventricular dysfunction.
|
J Cardiovasc Magn Reson
|
2006
|
0.84
|
|
106
|
The value of magnetic resonance imaging for the diagnosis of arrhythmogenic right ventricular cardiomyopathy.
|
Eur Radiol
|
2005
|
0.84
|
|
107
|
Contractile response and mitral regurgitation after temporary interruption of long-term cardiac resynchronization therapy.
|
Eur Heart J
|
2005
|
0.84
|
|
108
|
The effect of internal thoracic artery grafts on long-term clinical outcomes after coronary bypass surgery.
|
J Thorac Cardiovasc Surg
|
2011
|
0.83
|
|
109
|
Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.
|
Eur Heart J
|
2008
|
0.83
|
|
110
|
Withdrawal of statins in patients with acute coronary syndromes.
|
Circulation
|
2003
|
0.82
|
|
111
|
Asymptomatic recurrences of atrial fibrillation after pulmonary vein isolation.
|
Europace
|
2006
|
0.82
|
|
112
|
Mechanisms of stress (takotsubo) cardiomyopathy.
|
Heart Fail Clin
|
2013
|
0.82
|
|
113
|
Ultrasound guided percutaneous thrombin injection in a radial artery pseudoaneurysm following percutaneous coronary intervention.
|
Clin Res Cardiol
|
2014
|
0.82
|
|
114
|
Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI Registry).
|
Am J Cardiol
|
2012
|
0.82
|
|
115
|
Incidence and predictors of target vessel revascularization after sirolimus-eluting stent treatment for proximal left anterior descending artery stenoses among 2274 patients from the prospective multicenter German Cypher Stent Registry.
|
Clin Res Cardiol
|
2007
|
0.81
|
|
116
|
Implications of troponin testing in clinical medicine.
|
Curr Control Trials Cardiovasc Med
|
2001
|
0.81
|
|
117
|
Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
|
JACC Cardiovasc Interv
|
2010
|
0.81
|
|
118
|
Primary stenting of the left main coronary artery with anomalous origin from the right sinus of valsalva.
|
Int J Cardiol
|
2005
|
0.81
|
|
119
|
Cardiac angiosarcoma diagnosed and characterized by cardiac magnetic resonance imaging.
|
Cardiol Rev
|
2006
|
0.81
|
|
120
|
Right ventricular adaptation to pulmonary pressure load in patients with chronic thromboembolic pulmonary hypertension before and after successful pulmonary endarterectomy--a cardiovascular magnetic resonance study.
|
J Cardiovasc Magn Reson
|
2014
|
0.81
|
|
121
|
The Swedish paradox: or is there really no gender difference in acute coronary syndromes?
|
Eur Heart J
|
2011
|
0.81
|
|
122
|
Long-term follow-up after coronary stenting with the sirolimus-eluting stent in clinical practice: results from the prospective multi-center German Cypher Stent Registry.
|
Clin Res Cardiol
|
2012
|
0.81
|
|
123
|
Sirolimus eluting stent (Cypher) in patients with diabetes mellitus: results from the German Cypher Stent Registry.
|
Clin Res Cardiol
|
2007
|
0.81
|
|
124
|
Effects of gold coating of coronary stents on neointimal proliferation following stent implantation.
|
Am J Cardiol
|
2002
|
0.81
|
|
125
|
Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study.
|
Am Heart J
|
2013
|
0.81
|
|
126
|
Coronary CT angiography-derived fractional flow reserve correlated with invasive fractional flow reserve measurements--initial experience with a novel physician-driven algorithm.
|
Eur Radiol
|
2014
|
0.81
|
|
127
|
Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry.
|
Heart Vessels
|
2011
|
0.81
|
|
128
|
Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction.
|
Heart
|
2014
|
0.80
|
|
129
|
Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry.
|
Am Heart J
|
2006
|
0.80
|
|
130
|
Treatment of in-stent restenosis with sirolimus-eluting-stents: results from the prospective German Cypher stent registry.
|
Clin Res Cardiol
|
2008
|
0.79
|
|
131
|
Impact of diabetes mellitus status on coronary pathoanatomy and interventional treatment: insights from the Euro heart survey PCI registry.
|
Catheter Cardiovasc Interv
|
2011
|
0.79
|
|
132
|
[Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes].
|
Rev Port Cardiol
|
2008
|
0.79
|
|
133
|
Coronary interventions in the elderly.
|
Heart
|
2006
|
0.79
|
|
134
|
A prospective, single-blind, multicenter, dose escalation study of intracoronary iNOS lipoplex (CAR-MP583) gene therapy for the prevention of restenosis in patients with de novo or restenotic coronary artery lesion (REGENT I extension).
|
Hum Gene Ther
|
2011
|
0.79
|
|
135
|
Coronary stenting with the sirolimus-eluting stent in clinical practice: final results from the prospective multicenter German Cypher Stent Registry.
|
J Interv Cardiol
|
2009
|
0.79
|
|
136
|
Atrial septal defects type II: noninvasive evaluation of patients before implantation of an Amplatzer Septal Occluder and on follow-up by magnetic resonance imaging compared with TEE and invasive measurement.
|
Eur Radiol
|
2008
|
0.79
|
|
137
|
Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials.
|
J Thromb Thrombolysis
|
2015
|
0.79
|
|
138
|
P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC study.
|
Thromb Haemost
|
2015
|
0.79
|
|
139
|
Bone marrow-derived cells contribute to cell turnover in aging murine hearts.
|
Int J Mol Med
|
2012
|
0.79
|
|
140
|
Pulmonary vein antrum isolation and terminal part of the P wave.
|
Pacing Clin Electrophysiol
|
2010
|
0.79
|
|
141
|
Radiation dose exposure in multislice computed tomography of the coronaries in comparison with conventional coronary angiography.
|
Int J Cardiol
|
2007
|
0.78
|
|
142
|
Clinical pharmacology: antiplatelet therapy during surgery.
|
Heart
|
2010
|
0.78
|
|
143
|
Learning curve in cryoballoon ablation of atrial fibrillation: eight-year experience.
|
Circ J
|
2014
|
0.78
|
|
144
|
Acute aortitis with spinal artery aneurysms detected by contrast enhanced magnetic resonance imaging.
|
Clin Res Cardiol
|
2008
|
0.78
|
|
145
|
Multi-detector computed tomography is equivalent to trans-oesophageal echocardiography for the assessment of the aortic annulus before transcatheter aortic valve implantation.
|
Eur Radiol
|
2012
|
0.77
|
|
146
|
Images in cardiovascular medicine. Natural tissue engineering inside a ventricular septum defect occluder.
|
Circulation
|
2006
|
0.77
|
|
147
|
Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents.
|
J Am Soc Echocardiogr
|
2002
|
0.77
|
|
148
|
Electrical storm in a patient with arrhythmogenic right ventricular cardiomyopathy and SCN5A mutation.
|
Europace
|
2008
|
0.77
|
|
149
|
Limitations of biomarkers serum levels during pulmonary vein isolation.
|
Rev Esp Cardiol
|
2010
|
0.77
|
|
150
|
High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial.
|
Heart
|
2011
|
0.77
|
|
151
|
Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial.
|
J Am Coll Cardiol
|
2016
|
0.77
|
|
152
|
Calcium and C-reactive protein hot enough to predict the future?
|
J Am Coll Cardiol
|
2011
|
0.77
|
|
153
|
Cryoballoon ablation of atrial fibrillation: How important is the proper selection of patients?
|
Cardiol J
|
2015
|
0.76
|
|
154
|
Cobalt-chrome MULTI-LINK VISION-stent implantation in diabetics and complex lesions: results from the DaVinci-Registry.
|
Clin Res Cardiol
|
2009
|
0.76
|
|
155
|
Diagnostic value of the 16-detector row multislice spiral computed tomography for the detection of coronary artery stenosis in comparison to invasive coronary angiography.
|
Clin Cardiol
|
2007
|
0.76
|
|
156
|
Sirolimus-eluting stent treatment for unprotected versus protected left main coronary artery disease in widespread clinical routine: 6-month and 3-year clinical follow-up results from the prospective multicentre German Cypher Registry.
|
Heart
|
2007
|
0.76
|
|
157
|
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
|
Am Heart J
|
2005
|
0.76
|
|
158
|
Coronary stenting with the sirolimus-eluting stent in patients with restenosis after intracoronary brachytherapy: results from the prospective multicentre German Cypher Stent Registry.
|
Clin Res Cardiol
|
2009
|
0.75
|
|
159
|
[Acute coronary syndrome with and without ST elevation].
|
Herz
|
2006
|
0.75
|
|
160
|
Troponin: more lessons to learn.
|
Eur Heart J
|
2013
|
0.75
|
|
161
|
Reduction of neointimal hyperplasia in porcine coronary arteries by 2-deoxy-D-glucose.
|
Clin Res Cardiol
|
2009
|
0.75
|
|
162
|
[Transcatheter aortic valve implantation].
|
Herz
|
2010
|
0.75
|
|
163
|
Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics.
|
Clin Res Cardiol
|
2010
|
0.75
|
|
164
|
Venn diagrams in cardiovascular disease: the Heart Team concept.
|
Eur J Cardiothorac Surg
|
2013
|
0.75
|
|
165
|
Comparison of twelve-month outcomes after percutanous coronary intervention with everolimus-eluting versus zotarolimus-eluting or sirolimus-eluting stents from the PROENCY (PROmus ENdeavor CYpher) registry.
|
J Invasive Cardiol
|
2012
|
0.75
|
|
166
|
Pulmonary vascular remodeling before and after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a cardiac magnetic resonance study.
|
Int J Cardiovasc Imaging
|
2014
|
0.75
|
|
167
|
[Tako-Tsubo cardiomyopathy--a novel cardiac entity?].
|
Herz
|
2006
|
0.75
|
|
168
|
Anticoagulation in percutaneous coronary interventions: no man's land?
|
Eur Heart J
|
2010
|
0.75
|
|
169
|
Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials.
|
EuroIntervention
|
2017
|
0.75
|
|
170
|
Effects of tirofiban on hemostatic activation and inflammatory response during cardiopulmonary bypass.
|
Am J Cardiol
|
2003
|
0.75
|
|
171
|
Real-time three-dimensional echocardiographic diagnosis of postmyocardial infarction ventricular septal defect and guidance of transcatheter closure.
|
Heart
|
2007
|
0.75
|
|
172
|
Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: 18-month angiographic results from the GERSHWIN Study.
|
Herz
|
2007
|
0.75
|
|
173
|
"Off-Hours" Versus "On-Hours" Presentation in ST-Segment Elevation Myocardial Infarction: CHAMPION PHOENIX Findings.
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
174
|
Score associated with the outcome after multiple ablation procedures in patients with atrial fibrillation.
|
Pacing Clin Electrophysiol
|
2014
|
0.75
|
|
175
|
[Acute coronary syndromes without ST segment elevation].
|
Herz
|
2009
|
0.75
|
|
176
|
Long-term clinical outcome after implantation of the self-expandable STENTYS stent in a large, multicenter cohort.
|
Coron Artery Dis
|
2017
|
0.75
|
|
177
|
Ipsilateral circumferential radiofrequency ablation of atrial fibrillation with irrigated tip catheter: long-term outcome and pre-procedural predictors.
|
Circ J
|
2013
|
0.75
|
|
178
|
Simultaneous Isolation of High Quality Cardiomyocytes, Endothelial Cells, and Fibroblasts from an Adult Rat Heart.
|
J Vis Exp
|
2017
|
0.75
|
|
179
|
[Aortic Valve Stenosis: When to Treat Interventionally, when Surgically?]
|
Dtsch Med Wochenschr
|
2017
|
0.75
|
|
180
|
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study.
|
Thromb Haemost
|
2017
|
0.75
|
|
181
|
[Treatment of ST segment elevation myocardial infarctions according to the guidelines].
|
Herz
|
2005
|
0.75
|
|
182
|
Implantation of a novolimus-eluting bioresorbable scaffold with a strut thickness of 100 µm showing evidence of self-correction.
|
EuroIntervention
|
2015
|
0.75
|
|
183
|
TAVI risk scoring using established versus new scoring systems: role of the new STS/ACC model.
|
EuroIntervention
|
2017
|
0.75
|
|
184
|
Left ventricular function determines the survival benefit for women over men after transcatheter aortic valve implantation (TAVI).
|
EuroIntervention
|
2017
|
0.75
|
|
185
|
Predictors of recurrent stroke after percutaneous closure of patent foramen ovale.
|
EuroIntervention
|
2014
|
0.75
|
|
186
|
Venn diagrams in cardiovascular disease: the Heart Team concept.
|
Ann Thorac Surg
|
2013
|
0.75
|
|
187
|
Bioresorbable scaffolds in daily clinical routine: a practical review of all-comers results.
|
Curr Opin Cardiol
|
2015
|
0.75
|
|
188
|
[Oral antithrombotic therapy in primary and secondary prevention].
|
Herz
|
2005
|
0.75
|
|
189
|
Quantitative bedside testing of troponin T: is it equal to laboratory testing? The Cardiac Reader Troponin T (CARE T) study.
|
Clin Lab
|
2004
|
0.75
|
|
190
|
Angiographic, intravascular ultrasound, and fractional flow reserve evaluation of direct stenting vs. conventional stenting using BeStent2 in a multicentre randomized trial.
|
Eur Heart J
|
2005
|
0.75
|
|
191
|
Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II).
|
EuroIntervention
|
2009
|
0.75
|
|
192
|
Impact of presentation and transfer delays on complete ST segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial.
|
EuroIntervention
|
2017
|
0.75
|
|
193
|
Predictors of early and late left atrial tachycardia and left atrial flutter after catheter ablation of atrial fibrillation: Long-term follow-up.
|
Cardiol J
|
2015
|
0.75
|
|
194
|
Left circumflex artery-related myocardial infarction: does ST elevation matter? Results from the Euro Heart Survey PCI registry.
|
Int J Cardiol
|
2013
|
0.75
|
|
195
|
Transient elevation of NT-pro-BNP as a predictor for myocardial ischemia.
|
Clin Res Cardiol
|
2010
|
0.75
|
|
196
|
A randomised controlled trial of upstream administration of eptifibatide in patients presenting non-ST segment elevation acute coronary syndrome treated with an invasive strategy.
|
EuroIntervention
|
2007
|
0.75
|
|
197
|
Multiple episodes of a transient global left ventricular dysfunction reminiscent to apical ballooning.
|
Cardiology
|
2006
|
0.75
|
|
198
|
[Interventional therapy of bypass stenoses].
|
Herz
|
2002
|
0.75
|
|
199
|
Recurrent angina after complete coronary revascularization.
|
Clin Res Cardiol
|
2007
|
0.75
|
|
200
|
The sirolimus-eluting coronary stent in clinical practice: impact of direct stenting versus stenting with balloon pre-dilatation.
|
EuroIntervention
|
2007
|
0.75
|